MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Novel p.Pro193Arg missense mutation in ABCD1-gene associated with phenotype of ALD/AMN: a case report

    K. Steidel, J. Waldthaler, C. Eggers, D. Pedrosa (Marburg, Germany)

    Objective: To describe a novel mutation p.Pro193Arg of the ABCD1-Gene in a patient presenting with clinical phenotype of Adrenomyeloneuropathy (AMN). Background: Adrenoleukodystrophy comprises progressive neurologic…
  • 2019 International Congress

    The longevity gene Klotho and its CSF protein profiles as modifier for Parkinson´s disease in a longitudinal study

    M. Zimmermann, S. Lerche, C. Schulte, I. Wurster, G. Machetanz, C. Deuschle, A. Hauser, T. Gasser, D. Berg, E. Schleicher, W. Maetzler, K. Brockmann (Tuebingen, Germany)

    Objective: Our objective was to evaluate phenotype modifying effects of variants in longevity genes in PD. Background: Parkinson´s disease (PD) has a large phenotypic variability,…
  • 2019 International Congress

    Temporal Emergence of Symptoms and Functional Impairments in Patients With Pantothenate Kinase-Associated Neurodegeneration (PKAN)

    F. Greblikas, HA. Jinnah, T. Klopstock, A. Videnovic, C. Burns (San Diego, CA, USA)

    Objective: To describe the temporal emergence of PKAN symptoms and functional impairments across the spectrum of PKAN severity. Background: PKAN, an autosomal recessive, progressive neurodegenerative…
  • 2019 International Congress

    Case report: Chorea-acynthocytosis with two compoud heterozygous VPS13A large deletions

    D. Spieler, A. Mühlbäck, A. Velayos-Baeza, F. Castrop, C. Maegerlein, J. Slotta-Hispenina, B. Bader, B. Haslinger, J. Klempir, A. Danek (Freiburg, Germany)

    Objective: We report a 33 year old male patient without functional protein due to compound heterozygosity for VPS13A deletions and discuss the molecular diagnostic difficulties…
  • 2019 International Congress

    The effect of ATP13A2/PARK9 levels on a-syn spreading in mice brains

    T. Tsunemi, Y. Ishiguro, A. Okuzumi, A. Yoroisaka, N. Nukina, N. Hattori (Tokyo, Japan)

    Objective: The purpose of this study is to analyze the effect of ATP13A2/PARK9-mediated a-syn secretion on a-syn spreading in mice. Background: Recent studies with cell…
  • 2019 International Congress

    Longitudinal analysis of the modified Hoehn and Yahr disease stage in PD-1101, a Phase 1b clinical study of VY-AADC01

    A. van Laar, R. Richardson, A. Sedkov, E. Fine, K. Bankiewicz, B. Ravina, P. Larson, C. Christine (Pittsburgh, PA, USA)

    Objective: To describe changes over the first year in disease severity and activities of daily living using modified Hoehn and Yahr (mH&Y) stage and UPDRS…
  • 2019 International Congress

    Social Network for the diagnosis of RLS

    C. Guerra-Galicia, J. Blanco-Galina (San Luis Potosí, Mexico)

    Objective: Identify patients with RLS using social media, describe time of evolution, previous diagnosis, treatment, symptoms severity and quality of life perception. Background: RLS is a…
  • 2019 International Congress

    Pilot Study Comparing Home Sleep Profiler to In-laboratory Polysomnogram for REM Sleep Behavior Disorder Diagnosis

    D. Shprecher, D. Levendowski, C. Guevarra, J. Lee-Iannotti, G. Lazarz (Sun City, AZ, USA)

    Objective: To compare the Sleep Profiler (SP), an FDA-approved device for home evaluation of sleep disorders, to the gold standard sleep laboratory polysomnogram (PSG) in…
  • 2019 International Congress

    “So much easier”; patient’s perceptions of Virtual Clinics for Parkinson’s Disease

    L. Evans, B. Mohamed, EC. Thomas (Cardiff, United Kingdom)

    Objective: Our virtual clinic for People with Parkinson’s disease (PwP) is a service innovation, providing a consultation with a Parkinson’s clinic doctor via telephone, with…
  • 2019 International Congress

    Motor and non-motor symptoms burden, autonomy, quality of life and principal caregiver status is worse in patients with 5-2-1 positive criteria: a simple screening tool for identifying PD patients who need an optimization of Parkinson´s treatment.

    D. Santos, T. de Deus, E. Suárez Castro, A. Aneiros (A Coruña, Spain)

    Objective: To compare quality of life (QoL), non-motor symptoms (NMS) burden, autonomy for activities of daily living (ADL) and patient´s principal caregiver status in PD…
  • « Previous Page
  • 1
  • …
  • 212
  • 213
  • 214
  • 215
  • 216
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley